Financial Performance Highlights

Q2 FY27 Consolidated Results (₹ Million)

  • Revenue from Operations: ₹2,173 (vs. Q2FY26: ₹1,235, +76% YoY; vs. Q1FY27: ₹1,671, +30% QoQ)
  • Total Income: ₹2,191 (vs. Q2FY26: ₹1,245, +76% YoY)
  • EBITDA (Excl. Other Income): ₹407 (vs. Q2FY26: ₹222, +83% YoY)
  • EBITDA Margin: 19% (vs. Q2FY26: 18%)
  • Profit Before Tax: ₹289 (vs. Q2FY26: ₹137, +112% YoY)
  • Profit After Tax: ₹215 (vs. Q2FY26: ₹99, +116% YoY)
  • PAT Margin: 10% (vs. Q2FY26: 8%)

H1 FY27 Consolidated Results (₹ Million)

  • Revenue from Operations: ₹3,844 (vs. H1FY26: ₹2,404, +60% YoY)
  • Total Income: ₹3,889 (vs. H1FY26: ₹2,425, +60% YoY)
  • EBITDA (Excl. Other Income): ₹730 (vs. H1FY26: ₹395, +85% YoY)
  • EBITDA Margin: 19% (vs. H1FY26: 16%)
  • Profit Before Tax: ₹501 (vs. H1FY26: ₹228, +120% YoY)
  • Profit After Tax: ₹374 (vs. H1FY26: ₹166, +126% YoY)

Operational Challenges

During Q2 FY27, the company experienced significant cost pressures from:

  • Erratic short supplies of solvents leading to 60%-100% price increases
  • Rampant increase in global freight costs, particularly in US and Europe sectors with over 100% increases
  • These factors increased overall raw material costs despite healthy revenue growth in highest margin SDA business

Management Outlook

  • Expects raw material and freight cost trends to normalize within Q3 FY27
  • Foresees revenue growth continuing with similar momentum in coming quarters
  • Anticipates EBITDA margins to resume healthy trajectory
  • Priority is to sustain revenue momentum and ensure growth translates into healthy & sustainable profits

Business Segment Performance

Phase Transfer Catalysts (PTC)

  • Manufacturing since 1996
  • FY26 Revenue: ₹1,173 million (23% of total revenue)
  • H1FY27 Revenue: ₹881 million (23% of total revenue)
  • One of leading producers with entire wide range of PTCs in India

Structure Directing Agents (SDA)

  • Manufacturing since 2015
  • FY26 Revenue: ₹2,045 million (41% of total revenue)
  • H1FY27 Revenue: ₹1,546 million (40% of total revenue)
  • 2nd largest manufacturer of SDAs for Zeolites globally
  • EURO 7 emission standards implementation translating into meaningful sales contribution

Electrolyte Salts & Solutions (ESS)

  • Manufacturing since 2016
  • FY26 Revenue: ₹165 million (3% of total revenue)
  • Q1FY27 Revenue: ₹132 million (3% of total revenue)
  • Largest producer of electrolyte salts for super capacitor batteries in India
  • Engagement with existing customers remains encouraging
  • Hybrid-battery application progressing towards commercialization

Pharmaceuticals and Agrochemicals Intermediates (PASC)

  • Manufacturing since 2016
  • FY26 Revenue: ₹1,623 million (32% of total revenue)
  • Q1FY27 Revenue: ₹1,247 million (32% of total revenue)
  • Largest producer of Glymes in India and third largest globally
  • Recently commercialized agro products performing well
  • Pharma products beginning to contribute to business

Semiconductor Chemicals

  • Progress across all five products in development portfolio
  • Each advancing through respective stages of development, validation and customer qualification

Manufacturing and Capacity

  • Plants located at Ankleshwar and Dahej SEZ, Gujarat
  • Combined installed reactor capacity: 791KL
  • 39 Assembly Lines as on 31 March 2026
  • Ankleshwar facility converted to 'zero liquid effluent discharge' from January 2020
  • New greenfield project progressing as per planned schedule

Research & Development

  • R&D facility at Vadodara recognized by DSIR
  • R&D team of 56 employees including 26 senior scientists as of 30 September 2026
  • R&D capital and revenue expenditure: ₹300 million
  • Focus on 'green' chemistry processes including electrolysis and continuous flow chemistry

Geographic Presence

  • Exports constitute 75% of FY26 revenue
  • Customer base spanning over 30 countries including USA, UK, China, Germany, Japan, South Africa
  • Overseas subsidiaries: Tatva Chintan USA Inc. and Tatva Chintan Europe BV (Netherlands)
  • Warehousing facilities at Amsterdam, Netherlands and Savanna, USA

Capital Structure and Shareholding

  • Share Price (as on 30 September 2026): ₹1,784.20
  • Market Capitalization: ₹41,736 million
  • Free Float: 27.98%
  • Free Float Market Cap: ₹11,678 million
  • Shares Outstanding: 23,392,055
  • Promoter Holding: 72.02%

Credit Rating

  • CRISIL A-/Stable & A2+